Call It Preclinical or Subclinical, ILD in RA Needs to Be Tracked

Despite ILD being a leading cause of death in RA patients, there are no clinical guidelines for monitoring this lung condition in this population, experts say.

Related Keywords

Minnesota ,United States ,New York ,California ,Mayo Clinic In Rochester ,Hospital For Special Surgery ,Denver ,Colorado ,Elizabethr Volkmann ,Los Angeles ,Jessicak Gordon ,Johnm Davis ,Program At University Of California ,National Jewish Health In Denver ,Connective Tissue Disease ,Related Interstitial Lung Disease ,Medscape Medical ,Lancet Rheumatology ,Mayo Clinic ,Special Surgery ,New York City ,Future Research ,National Jewish Health ,Rheumatoid Arthritis ,A ,Lung ,Interstitial Lung Disease ,Arthritis ,Oint Inflammation ,Preventive Screening ,Screening ,Otolaryngology ,Nt Ears ,Nose ,Throat ,Clinical Guidelines ,Guidelines ,Computed Tomography ,It ,Scleroderma ,Crest Syndrome ,Cough ,Exercise ,Physical Activity ,Systemic Sclerosis ,Diffuse Scleroderma ,Tissue ,Arthralgia ,Ainful Joint ,Joint Pain ,Pain M ,